Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
Branger J, van den Blink B, Weijer S, Madwed J, Bos CL, Gupta A, Yong CL, Polmar SH, Olszyna DP, Hack CE, van Deventer SJ, Peppelenbosch MP, van der Poll T.
Branger J, et al. Among authors: weijer s.
J Immunol. 2002 Apr 15;168(8):4070-7. doi: 10.4049/jimmunol.168.8.4070.
J Immunol. 2002.
PMID: 11937566
Clinical Trial.